Minggu, 04 Juni 2017

Lynparza significantly reduces the risk of disease worsening in patients with BRCA mutations - study - ETHealthworld.com


ETHealthworld.com

Lynparza significantly reduces the risk of disease worsening in patients with BRCA mutations - study
ETHealthworld.com
Lynparza significantly reduces the risk of disease worsening in patients with BRCA mutations - study AstraZeneca today presented positive results from its Phase III OlympiAD trial that showed a statistically-significant and clinically-meaningful ...

and more »


from Health - Google News http://ift.tt/2qUv8lQ


EmoticonEmoticon